Trusted Pharmaceutical Manufacturer From India To Uzbekistan

Actiza Pharmaceutical Pvt. Ltd: Leading Indian Manufacturer Catering to Uzbekistan Medical Needs

Actiza Pharmaceutical Pvt. Ltd. It is an emerging pharmaceutical firm in India. It is known for making high-quality generic medicines and pharmaceutical products.

The company has built a big presence in many foreign markets. It did this by strictly following quality standards and rules. This includes Uzbekistan.

Actiza Pharmaceutical Pvt Ltd. extensive product range includes tablets, capsules, injectables, and ointments. Designed to meet the needs of specific therapeutic subgroups.

The organization provides assurance of dependable product quality. They have years of experience in pharmaceutical manufacturing.

Brief overview of the relationship between India and Uzbekistan in the pharmaceutical sector

Trade Growth:

Trade in pharmaceuticals between India and Uzbekistan has grown a lot. It shows that their relationship is getting stronger.

In the past, India and Uzbekistan traded USD 584 million worth of goods with each other. The last decade shows a steady rise in trade between the countries, from 248 million dollars in 2014.

Regulatory Collaboration:

 Trying to make rules more consistent to make sure drugs are safe and of good quality. Cooperation between regulatory bodies to make trade go more smoothly. Huge presence in the market:

Market scenario:

Indian drug companies have a big presence in Uzbekistan. There is a wide range of products, from generic drugs to specific drugs. The amount of medicines India sent to Uzbekistan rose by 20% in the last five year. A little over 20% of Uzbekistan’s pharmaceutical supplies come from India.

Healthcare Contributions:

Indian pharmaceuticals make a big difference in Uzbekistan’s healthcare. They do this by making medicines cheaper. More people are working together on medical studies and health care services.

Importance of pharmaceutical trade between the two countries

The trade in drugs between India and Uzbekistan is vital. It is key for many reasons. In Uzbekistan, it assures the availability of good and cheap medicines.

This fulfills key healthcare needs. This commerce supports Uzbekistan’s healthcare. It helps to improve the health of its people. It adds to the prosperity of both countries in two ways.

First, it increases trade volume and investment chances. This bilateral relationship will strengthen. Collaborative efforts in regulatory harmonization and medical research will benefit both countries.

India-Uzbekistan Pharmaceutical Trade Relations

Historical Context:

India and Uzbekistan have had diplomatic ties since 1992. Their relationship has been strengthened by regular high-level visits and cultural exchanges. This strategic relationship includes strong economic cooperation and cultural exchanges. They lay the groundwork for long-term trade ties.

Current Trade Relations:

In 2020-21, trade between India and Uzbekistan hit $442 million. Pharmaceuticals made up a big part of that. India is important to Uzbekistan’s trade. It supplies them with many cheap medicines and vaccines.

Regulatory Environment:

To make trade easier, the rules that govern India and Uzbekistan have been simplified. Pharmaceutical goods must meet quality and safety standards. This is thanks to agreements that have been made. This makes following the rules easier for businesses on both sides.

Wide Range of Effective Pharma Formulations Manufactured at Actiza Pharmaceutical Pvt Ltd.

We can help a lot of people get high-quality pharmaceutical treatments because our production sites are the best in the world.

As a pharmaceutical company, we have worked on antibiotics, diabetes, fever, infection, cold, neuroprotective drugs, skin care creams, dermatology ointments, gynecology, pediatrics, and other areas.

We can make a lot of things because our staff is very skilled and we use cutting-edge technology. We’re the best third-party manufacturing company in India because we have a good track record with our customers.

• Capsule
• Tablet
• Injection
• Creams / Ointment
• Drops
• Gel
• Suspension/syrup
• Nasal Drops/Sprays
• Eye/EarDrops
• Infusion
• Inhaler
• Lotion

Overview of the Pharmaceutical Market in Uzbekistan

In 2022, Uzbekistan’s pharmaceutical market was worth UZS 19.9 trillion, which is about US$1.8 billion. Prescription drugs made up 78% of the market, while over-the-counter meds made up the other 22%

• Marketing authorization (MA) – All drugs must pass state registration with MoH. They must also have a foreign issued MA. This is for smooth sales in the country. 
• Labeling and packaging – Each medicine must be packed properly to avoid any contamination of the drugs
• Serialization – The serialization codes are assigned to each unit. We can trace the medicine in the market with the help of these codes.
• GMP inspections – Every medicine in the market must be manufactured with compliance of GMP.
• Price controls– The Uzbekistani price is set by a reference pricing method. The price in the country of origin is used to figure this out.
• Distribution– Pricing rules and pharmaceutical rules, such as good distribution practice (GDP) and good storage practice (GSP), must be followed by wholesalers.
• Advertising – Medicine advertising is tightly controlled to protect the public and help people use medicines correctly. Medicines that can only be bought with a prescription can’t have ads.
• Local presence -To make sure that serialization works and that customer issues are handled properly, drug companies will need to either have a local office or send someone to do so.
• Local partners -Because the market is always changing, you should be very careful when picking a local partner.

Benefits of this trade relationship for both countries

• Market Expansion
• Economic Growth
• Job Creation
• Technological Collaboration
• Improved Healthcare
• Capacity Building
• Investment Attraction
• Strengthened Diplomatic Ties
• Supply Chain Optimization
• Innovation Boost

Statistical Data on the Pharmaceutical Market

It is estimated that the Pharmaceuticals market in Uzbekistan will bring in US$574.90m in 2024.

This year, the Oncology Drugs market is expected to bring in US$53.15 million, making it the biggest of the bunch.

In the years to come, sales will grow at a rate of 0.36% per year (CAGR 2024–2029). This will raise the market value to US$585.20m by 2029.

There is much investment and new ideas in Uzbekistan’s drug business now. This is leading to the creation of new drugs and treatments.

Our Manufacturing Capabilities

We are proud of our cutting-edge manufacturing processes. They use state-of-the-art technology and strict quality standards.

We are experts at making certain goods or categories, and we follow strict international rules for regulation. Our skilled workers are committed to inventing new ideas.

Our factories have high-tech machines and robots. They make sure the production process runs well and the quality of our products stays high.

They also to making things better and meeting all of our clients’ needs. They do all this while upholding the highest safety and environmental standards.

Description of our manufacturing facilities in India

Our team is highly professional. They work with the machines to make high-quality, cost-efficient products. Our world-class manufacturing plant is equipped with following things:

• Modern high-speed machines
• Integrated packaging lines
• Heavily automated systems
• Non-fill devices
• Collators
• Multi-station tablet presses
• Brevetti visual inspection machines
• FFS machines and high-speed vial/ampoule filler/sealer

Quality standards and certifications

• WHO-GMP Certification
• ISO 9001 Certification
• Environmental and Safety Standards
• Product-Specific Certifications

Meeting Uzbekistan’s Pharmaceutical Needs

• Adheres to Uzbekistan’s regulatory requirements.
• International norms (WHO-GMP) are met.
• Operates complex, cutting-edge factories.
• Sets up complete methods for quality control.
• Tests raw materials, items in progress, and finished goods thoroughly.
• Provides custom production options to meet the needs of each client.
• It makes sure that the delivery network works well. This ensures that deliveries happen on time.
• Adheres to rules and practices that are good for the environment.
• Always gets better based on what customers say.
• Has a number of local and foreign certifications.
• Spends money on research and development to find new answers.
• Offers reasonable prices without lowering the quality.
• Makes sure that Uzbekistan has easy access to health care options.
• It has strong backup plans in case something goes wrong.
• Makes sure that problems can be found and fixed quickly.

Quality Assurance and Compliance

• WHO-GMP Certification:

Actiza Pharmaceutical Pvt Ltd is WHO-GMP approved. This shows they are dedicated to high quality.

• Customized Solutions:

They offer production solutions. The solutions are made to fit Uzbekistan’s rules and regulations. They ensure that all levels of compliance are met.

• Strong Quality Management System:

Their quality management system covers all areas of quality control. It goes from getting the raw materials to delivering the finished goods.

• Approach Focused on the Customer:

They keep improving their processes to meet and exceed customer expectations. They do this by listening to and acting on customer comments.

Our vision for the future of India-Uzbekistan pharmaceutical relations

Our objective for India-Uzbekistan pharmaceutical ties is collaboration, innovation, and growth.

We’ll use India’s advanced pharmaceutical manufacturing. We’ll use Uzbekistan’s growing healthcare sector.

They will help us to further our collaboration. We dedicate ourselves to sustainability, compliance, and improvement.

This will lead to a strong, long-term partnership. It will benefit both nations, boost growth, and set a global industry standard.

Long-term goals for market expansion and innovation

• Increase compliance.
• Improve QA.
• Enhance manufacturing.
• Promote R&D
• Improve the supply chain.
• Foster sustainability.
• Grow market share.
• Improve the product portfolio.
• Invest in people.
• Use digital change.
• Focus on patients.
• Improve relations.

Conclusion

Our plan is long-term. It’s for the future of pharmaceutical ties between India and Uzbekistan.

It’s based on quality, new ideas, and teamwork. We want a strong partnership. It will meet the healthcare needs of both countries.

We will do this by coordinating standards, improving skills, and investing in research. Our eco-friendly methods, smooth supply chain, and patient-focused solutions grow our market share.

They also provide high-quality, low-cost healthcare goods. We aim to grow together, set new standards in pharma, and improve health in Uzbekistan.

We will do this by getting better and embracing digital transformation.